Patient Education and Rheumatoid Arthritis
PE and RA
Patient Education Program for Individuals With Rheumatoid Arthritis: A Randomized Controlled Trial
1 other identifier
interventional
88
1 country
1
Brief Summary
The goal of this clinical trial is to learn if a culturally adapted patient education program can help people with rheumatoid arthritis (RA) manage their disease and improve their quality of life. The main questions it aims to answer are:
- Does the program improve patients' knowledge, self-management skills, and confidence in dealing with RA?
- Does it lead to better quality of life and treatment adherence compared to usual care? Participants will:
- Join group sessions and individual activities focused on RA education, self-care, and stress management
- Take part in the program for 6 months, with regular follow-up visits
- Complete questionnaires about symptoms, daily activities, and quality of life
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable rheumatoid-arthritis
Started Sep 2025
Shorter than P25 for not_applicable rheumatoid-arthritis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 5, 2025
CompletedStudy Start
First participant enrolled
September 5, 2025
CompletedFirst Posted
Study publicly available on registry
September 12, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2026
CompletedSeptember 12, 2025
September 1, 2024
25 days
September 5, 2025
September 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
AIMS2 Quality of life
Change in health-related quality of life among participants, measured using validated patient-reported questionnaires (AIMS2) to assess physical, emotional, and social domains. The focus is on improvement in self-reported well-being and daily functioning.
Baseline to 6 months after randomization
Secondary Outcomes (4)
DAS-28
Baseline to 6 months after randomization
ASES
Baseline to 6 months after randomization
MARS
Baseline to 6 months after randomization
BDI
Baseline to 6 months after randomization
Study Arms (2)
Patient education Group
EXPERIMENTALA culturally adapted patient education program designed for individuals with rheumatoid arthritis. The program was developed through a structured needs assessment and based on established health behavior theories. It includes five core modules delivered over six months: understanding rheumatoid arthritis, monitoring disease activity, treatment strategies, nutrition, and stress management. Sessions combine group workshops and individual support, with interactive materials and practical exercises. The program aims to strengthen patients' knowledge, self-management skills, and quality of life compared to usual care.
Usual care Group
ACTIVE COMPARATORpatients will receive usual care only
Interventions
A culturally adapted patient education program designed for individuals with rheumatoid arthritis. The program was developed through a structured needs assessment and based on established health behavior theories. It includes five core modules delivered over six months: understanding rheumatoid arthritis, monitoring disease activity, treatment strategies, nutrition, and stress management. Sessions combine group workshops and individual support, with interactive materials and practical exercises. The program aims to strengthen patients' knowledge, self-management skills, and quality of life compared to usual care.
Eligibility Criteria
You may qualify if:
- Adults (≥18 years) diagnosed with rheumatoid arthritis according to ACR/EULAR 2010 classification criteria
- Stable pharmacological treatment for at least 3 months prior to enrollment
- Ability to participate in group sessions and complete questionnaires
- Provided written informed consent
You may not qualify if:
- Diagnosis of other systemic autoimmune or inflammatory rheumatic diseases (e.g., lupus, psoriatic arthritis)
- Severe comorbidities that may interfere with participation (e.g., advanced heart failure, uncontrolled psychiatric illness)
- Cognitive impairment or language barrier preventing comprehension of the program
- Participation in another structured patient education program within the last 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
university hospital IBN ROCHD
Casablanca, Morocco
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr BOUNABE ABDELAAZI
Study Record Dates
First Submitted
September 5, 2025
First Posted
September 12, 2025
Study Start
September 5, 2025
Primary Completion
September 30, 2025
Study Completion
March 30, 2026
Last Updated
September 12, 2025
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share